Jim Simons Spring Works Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $491,640 - $809,063	20,400 New	20,400 $582,000
Q2 2021 Aug 13, 2021	SELL	$67.45 - $85.63 $4.11 Million - $5.21 Million	-60,900 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$65.1 - $93.59 $2.01 Million - $2.88 Million	30,800 Added 102.33%	60,900 $4.48 Million
Q4 2020 Feb 10, 2021	BUY	$48.36 - $77.92 $918,840 - $1.48 Million	19,000 Added 171.17%	30,100 $2.18 Million
Q3 2020 Nov 13, 2020	BUY	$36.14 - $51.99 $401,154 - $577,089	11,100 New	11,100 $529,000
Q2 2020 Aug 13, 2020	SELL	$22.98 - $48.57 $349,296 - $738,264	-15,200 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$20.44 - $41.21 $310,688 - $626,392	15,200 New	15,200 $410,000

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.57B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.